Please ensure Javascript is enabled for purposes of website accessibility
홈 > 제품 > 항체 > 바이오시밀러

Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO) (HV974216)

Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)
Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)
Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)
Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)
Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)
Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)
Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)
Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)
가격(USD):
사양:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
수량:
문의하기
  • 개요

  • 이미지

  • 참고 문헌

  • 데이터시트

  • SDS

개요
카탈로그 번호HV974216
설명
Reozalimab (HV974216) is a research-grade recombinant antibody targeting CD1. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
종 반응성Human
응용 분야ELISA, Bioactivity: FCM, Functional assay, Research in vivo
숙주 종Human
클론성Monoclonal
이소타입Ig(G1-kappa_G1-lambda2)
테스트된 응용 분야 WB, FCM
타겟 B7 homolog 1, B7-H1, B7H1, CD274, PD-L1, PDCD1 ligand 1, PDCD1L1, PDCD1LG1, PDL1, Programmed cell death 1 ligand 1, Programmed death ligand 1, CD279, PD1, PDCD1, Programmed cell death protein 1, Protein PD-1
내독소 수준 < 10 EU/mg
순도 >95% as determined by SDS-PAGE.
정제 Protein A/G purified from cell culture supernatant.
등록번호 Q9NZQ7 & Q15116
형태 Liquid
저장 완충액 0.01M PBS pH 7.4.

데이터시트 인쇄본 또는 로트별 COA에 기재된 구체적인 완충액 정보를 참조하세요.

안정성 및 저장 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
대체 이름Bispecific, IBI318, IBI-318, IBI318, 2445259-99-2
배경Reozalimab is a bispecific antibody targeting to PD-1/PD-L1. Reozalimab mediates antibody-dependent cell cytotoxicity in cancer research.
참고사항 For research use only. Not suitable for clinical or therapeutic use.
이미지
  • Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)

    Bioactivity

    Detects PDL1 in indirect ELISA.

  • Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)

    Bioactivity

    Detects recombinant human PD1 (Cat No.: HS870021) in indirect ELISA.

  • Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)

    Flow CytoMetry

    Flow-cytometry using anti-human CD274 antibody. Untransfected cells (blue Histogram) and Transfected cells (Yellow Histogram) were stained with an anti-human CD274 monoclonal antibody (Catalog: HV974216) at a concentration of 5 µg/ml for 30 mins at RT. After washing, bound antibody was detected using a Goat Anti-Human IgG H&L Polyclonal Antibody, FITC (abinScience: HF690414) and cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human PD-1 & PD-L1 Bispecific Reference Antibody (Reozalimab, RUO)

    Western blot

    Western blot analysis was performed using anti-CD274/PD-L1/B7-H1 monoclonal antibody at 1ug/mL on various samples.
    Lane 1: recombinant human CD274/PD-L1/B7-H1 (Catalog No: HV974011)
    Lane 2: negative control

참고 문헌
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
추천

문의하기 맞춤형 견적, 대량 주문 및 기타 문의 사항은

메일: [email protected]

배급사 목록